•Artificial intelligence is rapidly accelerating the generation of novel drug candidates, creating an unprecedented volume of potential molecules for research.
•The emerging challenge for pharmaceutical R&D is no longer just generating candidates, but efficiently sifting through this 'drug flood' to identify truly promising compounds.
•A new startup is focused on leveraging advanced analytics and AI to pinpoint the most viable drug candidates from this immense output, streamlining early-stage discovery.
•Artificial intelligence is rapidly accelerating the generation of novel drug candidates, creating an unprecedented volume of potential molecules for research.
•The emerging challenge for pharmaceutical R&D is no longer just generating candidates, but efficiently sifting through this 'drug flood' to identify truly promising compounds.
•A new startup is focused on leveraging advanced analytics and AI to pinpoint the most viable drug candidates from this immense output, streamlining early-stage discovery.
